Search results
ARS Pharmaceuticals Inc (SPRY) Q1 2024 Earnings: Aligns with EPS Projections Amidst Regulatory ...
GuruFocus.com via Yahoo Finance Canada· 2 months agoNet Loss: Reported a net loss of $10.3 million for Q1 2024, slightly above the estimated net loss of $10.44 million. Revenue: Revenue details for Q1 2024 were not provided, unable to compare ...
Applied Therapeutics Inc (APLT) Announces Year-End 2023 Financial Results and Clinical Progress
GuruFocus.com via Yahoo Finance Canada· 4 months agoRevenue: Reported total revenue of $9.99 million for the year ended December 31, 2023. Net Loss:...
Pharma Stock Roundup: PFE Issues Weak 2024 View, AZN to Buy Icosavax & More
Zacks via Yahoo Finance Canada· 7 months agoThis week, Pfizer PFE issued a disappointing guidance for 2024, which includes its expectations from...
Pfizer's (PFE) Hemophilia Candidate BLA Gets FDA Acceptance
Zacks via Yahoo Finance Canada· 7 months agoThe FDA decision on Pfizer's (PFE) BLA for marstacimab for hemophilia A and B is expected in the...
Stock market: 4 hottest areas for growth in 2024
Yahoo Finance· 7 months agoInvestors looking for stock winners beyond this year's "Magnificent Seven" may have a broader selection to choose from in 2024. “Stock picking this year...
Q3 2023 Deciphera Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance Canada· 8 months agoParticipants Daniel C. Martin; Senior VP & Chief Commercial Officer; Deciphera Pharmaceuticals, Inc. Jennifer Larson; SVP of Finance & IR; Deciphera Pharmaceuticals, Inc. Margarida Duarte; Senior ...
Mid-America Apartment Communities, Inc. (NYSE:MAA) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance Canada· 8 months agoMid-America Apartment Communities, Inc. (NYSE:MAA) Q3 2023 Earnings Call Transcript October 26, 2023...
Biotech Stock Roundup: ALDX, EVLO Down on Setback, SRRK Offers Updates & More
Zacks via Yahoo Finance Canada· 9 months agoIt was a busy week for the biotech sector before the third-quarter earnings kicked in. While nothing...
J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe
Zacks via Yahoo Finance Canada· 10 months agoJ&J's (JNJ) erdafitinib is already marketed as Balversa in the United States for FGFR-altered...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
Zacks via Yahoo Finance Canada· 10 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
